Skip to main content
Top
Published in: Diabetologia 2/2004

01-02-2004 | Observation

Neutrophil antigen exposure is altered with age in relatives of patients with Type 2 diabetes

Authors: L. D. Rawling, Dr. A. Advani, S. M. Marshall, T. H. Thomas

Published in: Diabetologia | Issue 2/2004

Login to get access

Excerpt

To the Editor: Neutrophil dysfunction contributes to the pathogenesis of the vascular complications of Type 2 diabetes. Adhesion of neutrophils to the vascular endothelium is mediated by surface exposure of the β2 integrin CD11b/CD18, which is closely associated with the actin cytoskeleton [1]. We have shown that neutrophils respond to activation with phorbol ester by rapidly increasing surface expression of CD11b, followed by loss of surface CD11b in a proportion of cells [2]. Loss of surface CD11b in response to phorbol ester is associated with actin polymerisation and leads to loss of neutrophil adherence [3]. In Type 2 diabetes both the proportion of neutrophils polymerising actin and losing CD11b and the proportion of cells exocytosing primary granules (an important step in microbial killing and identified as surface exposure of the antigen CD69) is reduced [2]. …
Literature
1.
go back to reference Anderson SI, Hotchin NA, Nash GB (2000) Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils. J Cell Sci 113:2737–2745PubMed Anderson SI, Hotchin NA, Nash GB (2000) Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils. J Cell Sci 113:2737–2745PubMed
2.
go back to reference Advani A, Marshall SM, Thomas TH (2002) Impaired neutrophil actin assembly causes persistent CD11b expression and reduced primary granule exocytosis in Type 2 diabetes. Diabetologia 45:719–727CrossRef Advani A, Marshall SM, Thomas TH (2002) Impaired neutrophil actin assembly causes persistent CD11b expression and reduced primary granule exocytosis in Type 2 diabetes. Diabetologia 45:719–727CrossRef
3.
go back to reference Davey PC, Zuzel M, Kamiguti AS, Hunt JA, Aziz KA (2000) Activation-dependent proteolytic degradation of polymorphonuclear CD11b. Br J Haemat 111:934–942 Davey PC, Zuzel M, Kamiguti AS, Hunt JA, Aziz KA (2000) Activation-dependent proteolytic degradation of polymorphonuclear CD11b. Br J Haemat 111:934–942
4.
go back to reference Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG (1995) Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 123:919–924PubMed Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG (1995) Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 123:919–924PubMed
5.
go back to reference Noble JM, Ford GA, Thomas TH (1999) Effect of aging on CD11b and CD69 surface expression by vesicular insertion in human polymorphonuclear leucocytes. Clin Sci (Lond) 97:323–329 Noble JM, Ford GA, Thomas TH (1999) Effect of aging on CD11b and CD69 surface expression by vesicular insertion in human polymorphonuclear leucocytes. Clin Sci (Lond) 97:323–329
6.
go back to reference Balletshofer BM, Rittig K, Enderle MD et al. (2000) Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with Type 2 diabetes in association with insulin resistance. Circulation 101:1780–1784PubMed Balletshofer BM, Rittig K, Enderle MD et al. (2000) Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with Type 2 diabetes in association with insulin resistance. Circulation 101:1780–1784PubMed
7.
go back to reference Janssen JA, Lamberts SW (2002) The role of IGF-I in the development of cardiovascular disease in Type 2 diabetes mellitus: is prevention possible? Eur J Endocrinol 146:467–477PubMed Janssen JA, Lamberts SW (2002) The role of IGF-I in the development of cardiovascular disease in Type 2 diabetes mellitus: is prevention possible? Eur J Endocrinol 146:467–477PubMed
Metadata
Title
Neutrophil antigen exposure is altered with age in relatives of patients with Type 2 diabetes
Authors
L. D. Rawling
Dr. A. Advani
S. M. Marshall
T. H. Thomas
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1290-6

Other articles of this Issue 2/2004

Diabetologia 2/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine